For example, the active HER3–HER2 heterodimer has emerged as an important oncogenic unit in breast cancer, while the HER3–HER1 heterodimer drives melanoma and pancreatic carcinoma (Reschke et al., 2008 ▸; Liles et al., 2010 ▸). This evidence concerns the gene ERBB3 and breast cancer.